BETTY BANH: Open Payments
NPI 1215660394 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,734 in 68 payments from 21 companies in 2025. Trend: 2023 $1,397 · 2024 $1,289 · 2025 $1,734
Food & beverage: $1,635Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $281 |
| Endo USA, Inc. | 6 | $161 |
| Astellas Pharma US Inc | 4 | $154 |
| Sumitomo Pharma America, Inc. | 6 | $147 |
| Blue Earth Diagnostics | 4 | $129 |
| ABBVIE INC. | 6 | $129 |
| PROGENICS PHARMACEUTICALS, INC. | 5 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $103 |
| UROGEN PHARMA, INC. | 4 | $86 |
| Ferring Pharmaceuticals Inc. | 4 | $77 |
Products named: GEMTESA, RYBREVANT, ERLEADA, POSLUMA, PYLARIFY, XIAFLEX, Nubeqa, XTANDI.
Industry payments across AZ — which companies pay providers there.
